Katie M. Bush Joins Boutique Corporate Law Firm Nemphos Braue as Director of Business Development to Extend and Enrich Partnerships and Business Relationships
FOR IMMEDIATE RELEASE
April 15, 2024 ...
FOR IMMEDIATE RELEASE
April 15, 2024 ...
The Office of Central Services (OCS) has developed the Business Highway to create a one-stop source for engaging & connecting small, local & diverse suppliers to business development and procurement opportunities in the County. ...
New RFP supports goal to make Maryland a top-ten fastest-growing innovation economy; proposals due by August 1, 2022 ...
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeback Bio”), a biotechnology company focused on emerging infectious diseases, intended to create a collaboration to expand the availability of Ebanga™ (Ansuvimab-zykl). Under the terms of the contemplated collaboration, Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga™ in the United States and Canada, and Ridgeback Bio will serve as the global access partner for Ebanga™, ensuring it remains available to patients in endemic countries free of charge through Ridgeback Bio’s compassionate use program. Ebanga™ was approved by the U.S. Food and Drug Administration (FDA) in December 2020 for the treatment of Ebola. ...
ALTIMORE, MD (July 6, 2022) – The Maryland Department of Commerce has been awarded a $1.6 million grant from the Economic Development Administration (EDA), an agency within the U.S. Department of Commerce. The federal grant comes from the American Rescue Plan and will be matched with $396,000 from the state’s Maryland Economic Adjustment Fund (MEAF). The funding will be used to assist Maryland small businesses through MEAF’s revolving loan fund, with priority consideration given to businesses in Baltimore City and rural regions across the state. ...
In just the last few years, Novavax has grown dramatically — from 100 employees to nearly 1,600. The biotechnology company, based in Montgomery County, MD, makes a COVID-19 vaccine that is currently available globally, and is undergoing FDA review in the U.S. Unlike some other COVID vaccines, it can be stored at room temperature and is protein-based, just like other vaccines used for decades to protect against HPV, flu and shingles. ...
The Otterbein-based workforce training and data science company Catalyte recently got a chance to test its pipeline development strategies on a bigger stage by earning a nearly $15 million contract to develop tech talent for the State of Maryland. ...
Brexpiprazole shows positive phase III results. (Courtesy of SOPA Images/Getty Images) ...